2-Deoxy-fluorglucose-positron emission tomography imaging of the brain: Current clinical applications with emphasis on the dementias

Seminars in Nuclear Medicine

Volumn 34, Issue 4, 2004, Pages 300-312

  Van Heertum, Ronald L ^a,b   Greenstein, Elizabeth A ^a   Tikofsky, Ronald S ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b New Y ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TRACER;

ALZHEIMER DISEASE; ANALYTIC METHOD; BRAIN TUMOR; CEREBROVASCULAR DISEASE; DEMENTIA; ENVIRONMENT; EPILEPSY; HEAD INJURY; HUMAN; IMAGING; INSTRUMENTATION; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; REVIEW;

EID: 5544229749     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2004.03.003     Document Type: Article

References (70)

1. M. Iacoboni, J.C. Baron, R.S. Frackowiak Emission tomography contribution to clinical neurology Clin Neurophysiol 110 1999 2 23
2. M.E. Phelps, S.C. Huang, E.J. Hoffman Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose Validation of method Ann Neurol 6 1979 371 388
3. C.P. Derdeyn, R.L. Grubb, W.J. Powers Cerebral hemodynamic impairment Methods of measurement and association with stroke risk Neurology 53 1999 251 259
4. H. Yamauchi, H. Fukuyama, Y. Nagahama Evidence of misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive diseases from PET J Neurol Neurosurg Psychiatry 61 1996 18 25
5. M. Ichise, J.R. Ballinger SPECT imaging of dopamine receptors [editorial] J Nucl Med 37 1996 1591 1595
6. M. Laruelle, C. van Dyck, A. Abi-Dargham Compartmental modeling of iodine- 123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects J Nuc Med 35 1994 743 754
7. M.E. Phelps, S.R. Cherry The changing design of positron imaging systems Clinical Positron Imaging 1 1998 31 45
8. T. Beyer, D.W. Townsend, T. Brun A combined PET-CT scanner for clinical oncology J Nucl Med 41 2000 1369 1379
9. R.L. Van Heertum, R.S. Tikofsky Brain tumors, other disease, and activation R.L. Van Heertum R.S. Tikofsky Functional Cerebral SPECT and PET Imaging 3rd ed. 2000 Lippincott Williams & Wilkins Philadelphia 275 312
10. H.J. Biersack, F. Grunwal, J. Kropp Single photon emission computed tomography imaging of brain tumors Semin Nucl Med 21 1991 2 10
11. K.P. Ebmeiier, K. Booker, A. Gregor Single photon emission computed tomography in long term survivors of adult brain tumours J Neurol Neurosurg Psychiatry 57 1994 729 733
12. R. Rubinstein, H. Karger, U. Pietrzyk Use of (201)Thallium brain SPECT, image registration, and semi-quantitative analysis in the follow-up of brain tumors Eur J Radiol 21 1996 188 195
13. L.S. Kessler, A. Rjuiz, M.J. Donovan Thallium-201 brain SPECT of lymphoma in AIDS patients Pitfalls and technique optimization AJNR Am J Neuroradiol 19 1998 1105 1109
14. J.M. Mountz, G. Deutsche, R. Kuzniecky Brain SPECT 1994 update L.M. Freeman Nuclear Medicine Annual 1994 1994 Raven Press New York 1 54
15. J.M. Mountz, K. Stafford-Schuck, P.E. McKeever Thallium-201 SPECT tumor/cardiac ratio estimation of residual astrocytoma J Neurosurg 88 1988 705 709
16. K.T. Kim, K.L. Black, D. Marciano Thallium-201 SPECT imaging of brain tumors methods and results J Nucl Med 31 1990 965 969
17. C. Soler, P. Beauchesne, K. Maatougui Technetium-99m-sestamibi brain single-photon-emission tomography for detection of recurrent gliomas after radiation therapy Eur J Nucl Med 25 1998 1649 1657
18. R.B. Schwartz, P.A. Carvalo, E. Alexander III Radiation necrosis vs high-grade recurrent glioma differentiation by using dual-isostope SPECT with 201 Tl and Tc-HMPAO AJNR 12 1992 1187 1192
19. J.-P. Papazyan, J. Delavelle, P. Burkhard Discrepancies between HMPAO and ECD SPECT imaging in brain tumors J Nucl Med 38 1997 592 596
20. A. Soricelli, A. Cucolo, A. Varrone Technetium-99m-tetrofosmin uptake in brain tumors by SPECT comparison with thallium-201 imaging J Nucl Med 39 1998 802 806
21. F.G. Barker II, S.M. Chang, P.E. Valk (18)Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma Cancer 79 1997 115 126
22. A. Deshmukh, J.A. Scott, E.L. Palmer Impact of fluorodeoxyglucose positron emission tomography on the clinical management of patients with glioma Clin Nucl Med 21 1996 720 725
23. K. Ericson, I. Kihlstrom, J. Mogard Positron emission tomography using (18)F-fluorodeoxyglucose in patients with stereotactally irradiated brain metastases Stereotact Funct Neurosurg 66 suppl 1996 214 224
24. A.C. Kole, O.F. Neweg, J. Pruim Detection of unknown occult primary tumors using positron emission tomography Cancer 82 1998 1160 1166
25. D. Delbeke Oncological applications of FDG PET imaging Brain tumors, colorectal cancer, lymphoma and melanoma J Nucl Med 40 1999 591 603
26. L.P. Connolly, L.A. Drubach, S.T. Treves Applications of nuclear medicine in pediatric oncology Clin Nucl Med 27 2002 117 125
27. M. Utriainen, L. Metsahonkala, T.T. Salmi Metabolic characterization of childhood brain tumors comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography Cancer 95 2002 1376 1386
28. B. Pirotte, S. Goldman, S. Salzberg Combined positron emission tomography and magnetic resonance imaging for the planning of stereotactic brain biopsies in children experience in 9 cases Pediatr Neruosurg 38 2003 146 155
29. D. Ribom, A. Eriksson, M. Hartman Positron emission tomography (11)C- methionine and survival in patients with low-grade gliomas Cancer 92 2001 1541 1549
30. O. De Witte, I. Goldberg, D. Wikler Positron emission tomography with injection of methionine as a prognostic factor in glioma J Neurosurg 95 2001 746 750
31. J. Sorensen, I. Savitcheva I, H. Engler Utility of PET and 11C-Methionine in the paediatric brain tumors Clin Positron Imaging 3 2000 157
32. J.F. Kurtze Epidemiology of cerebrovascular disease F.H. Mc Dowell L.R. Caplan Cerebrovascular Survey Report 1985 1985 National Institutes of Health Bethesda, MD 1 34
33. R.L. Sacco, M. Elkind, B. Boden-Albala The protective effect of moderate alcohol consumption on ischemic stroke JAMA 281 1999 53 60
34. R.L. Van Heertum, A.B. Rubens, H.H. Coslett Cerebrovascular disease R.L. Van Heertum R.S. Tikofsky Functional Cerebral SPECT and PET Imaging 3rd ed. 2000 Lippincott Williams & Wilkins Philadelphia 67 126
35. R.L. Van Heertum, S.H. Miller, R.E. Mosesson SPECT brain imaging in neurologic disease Radiol Clin North Am 31 1993 881 907
36. A. Alzheimer Uber eine eigenartige Erkankung der Hirnirinde Allegmeine Zeitschrift fur Psychiatric 64 1907 146 148
37. M.S. Albert, D.A. Drachman Alzheimer's disease What is it, how many people have it, and why do we need to know? Neurology 56 2000 166 168
38. L.X. Hy, D.M. Keller Prevalence of AD among whites A summary by levels of severity Neurology 55 2000 198 204
39. R.L. Van Heertum, R.S. Tikofsky, A.B. Rubens Dementia R.L. Van Heertum R.S. Tikofsky Functional Cerebral SPECT and PET Imaging 3rd ed. 2000 Lippincott Williams & Wilkins Philadelphia 127 188
40. E. Witthaus, A. Ott, J.J. Barendregt Burden of mortality and morbidity from dementia Alzheimer Dis Assoc Disord 13 1999 176 181
41. G. McKhann, D. Drachman, M. Folstein Clinical diagnosis of Alzheimer's disease Report on NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1989 939 942
42. T. Wetterling, R.D. Kanitz, K.J. Borgis Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN) Stroke 27 1996 30 36
43. G.W. Small, J.C. Mazziotta, M.T. Collins Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease JAMA 273 1995 942 947
44. D. Cardebat, J.F. D'Emonet, M. Puel Brain correlates of memory processes in patients with dementia of Alzheimer's type A SPECT activation study J Cereb Blood Flow Metab 18 1998 457 462
45. C.I. Elfgren, E. Ryding, U. Passant Performance on neuropsychological tests related to single photon emission computerised tomography findings in frontotemporal dementia Br J Psychiatry 169 1996 416 422
46. H. Golan, J. Kremer, M. Freedman Usefulness of follow-up regional cerebral blood flow measurements by single-photon emission computed tomography in the differential diagnosis of dementia J Neuroimaging 16 1996 23 28
47. J.D. Greene, K. Miles, J.R. Hodges Neuropsychology of memory and SPECT in the diagnosis and staging of dementia of Alzheimer type J Neurol 243 1996 175 190
48. N. Kemppainen, H. Ruottinen, K. Nagron PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD Neurology 55 2000 205 209
49. J.C. Stoof, B. Drukarch, P. de Boer Regulation of the activity of striatal cholinergic neurons by dopamine Neuroscience 47 1992 755 770
50. J.M. Hoffman, M.W. Hanson, K.A. Welsh Interpretation variability of 18FDG-positron emission tomography studies in dementia Invest Radiol 31 1996 316 322
51. R. Mielke, W.D. Heiss Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia J Neurol Transm Suppl 53 1998 237 250
52. P.R. Talbot, J.J. Lloyd, J.S. Snowden A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia? J Neurol Neurosurg Psychiatry 64 1998 306 313
53. D.J. Brooks Functional imaging techniques in the diagnosis of non-Alzheimer dementias J Neurol Transm Suppl 47 1996 155 167
54. A.O. Ceballos-Baumann, H. Boecker, P. Bartenstein A positron emission tomographic study of subthalamic nucleus stimulation in parkinson disease enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity Arch Neurol 156 1999 997 1003
55. B.R. Ott, R.S. Faberman, R.B. Noto A SPECT imaging study of MRI white matter hyperintensity in patients with degenerative dementia Dement Geriatr Cogn Disord 8 1997 348 354
56. E.H. Corder, A.M. Saunders, W.J. Strittmatter Gene dose of apolipoprotein E type 4 and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923
57. E.H. Corder, A.M. Saunders, N.J. Risch Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease Nat Genet 7 1994 180 184
58. E.H. Corder, V. Jelic, H. Basun No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes Arch Neurol 54 1997 273 277
59. G.W. Small, J.C. Mazziotta, M.T. Collins Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease JAMA 273 1995 942 947
60. E.M. Reiman, R.J. Caselli, L.S. Yun Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E N Engl J Med 334 1996 752 758
61. M.D. Devous Sr, R.F. Leroy, R.W. Homan Single Photon emission computed tomography in epilepsy Semin Nucl Med 20 1990 325-241
62. T.R. Henry, R.L. Van Heertum PET imaging in the evaluation of epilepsy care Semin Nucl Med 32 2003 188 205
63. R.S. Tikofsky, R.L. Van Heertum Seizure disorders R.L. Van Heertum R.S. Tikofsky Functional Cerebral SPECT and PET Imaging 3rd ed. 2000 Lippincott Williams & Wilkins Philadelphia 189 228
64. M.D. Devous Sr, R.A. Thisted, G.F. Morgan SPECT brain imaging in epilepsy a meta-analysis J Nucl Med 39 1998 285 293
65. M.D. Devous Sr Comparison of SPECT applications in neurology and psychiatry J Clin Psychiatry 53 suppl 1992 13 19
66. S. Bavetta, C.C. Nimmon, J. McCabe A prospective study comparing SPET with MRI and CT as prognostic indicators following severe closed head injury Nucl Med Commun 15 1999 961 968
67. A. Jacobs, E. Put, M. Ingels Prospective evaluation of technitium-99m- HMPAO SPECT in mild and moderate traumatic brain injury J Nucl Med 35 1994 942 947
68. A.B. Newberg, A. Alavi Neuroimaging in patients with head trauma L.M. Freeman Nuclear Medicine Annua 1996 Lippincott-Raven Publishers Philadelphia 195 212
69. R.H. Reid, K.Y. Gulenchyn, J.R. Ballinger Cerebral perfusion imaging with technitium-99m HMPAO following cerebral trauma. Initial experience Clin Nucl Med 15 1990 383 388
70. R. Kant, L. Smith-Seemiller, G. Isaac Tc-HMPAO SPECT in persistent post-concussion syndrome after mild head injury Comparison with MRI/CT Brain Inj 11 1997 115 124